SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-070015
Filing Date
2024-06-06
Accepted
2024-06-06 17:50:59
Documents
2
Period of Report
2024-05-28

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2229
2 EX-24 lnth-ex24.htm EX-24 18683
  Complete submission text file 0000950170-24-070015.txt   22479
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Issuer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address C/O CONSTELLATION PHARMACEUTICALS, INC. 215 FIRST STREET, SUITE 200 CAMBRIDGE MA 02142
Business Address
Humphrey Jeffrey (Reporting) CIK: 0001816944 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36569 | Film No.: 241026620